Kiniksa: Increased Outlook For Arcalyst, Augmented By Pipeline Maturation
Breakfast News: Enphase Dips As Solar Demand Dims
Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge
Ross Moat Sells 1,703 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month High – Still a Buy?
Aberdeen Group plc Buys 241,876 Shares of Kiniksa Pharmaceuticals International, plc $KNSA
AI-Fueled Trio Leads 5 Stocks To Watch Near Buy Points
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of “Moderate Buy” from Analysts
Kiniksa Pharmaceuticals International Q4 Earnings Call Highlights
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call Transcript
Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?
Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Kiniksa Pharmaceuticals Provides Corporate Update
Mark Ragosa Sells 12,000 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Voya Investment Management LLC
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High – Time to Buy?
Barry Quart Sells 20,129 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock
Fisher Asset Management LLC Has $2.83 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA
AXQ Capital LP Makes New $289,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSA
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
New Strong Sell Stocks for Oct. 30th
Kiniksa: How Category Ownership And Higher Duration Are Translating Into Operating Leverage
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2025 Earnings Call Transcript
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings Miss Estimates
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis
Why Kiniksa Pharmaceuticals International, plc (KNSA) is Poised to Beat Earnings Estimates Again
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet
5 Biotech Stocks Worth Adding to Your Portfolio Now
Kiniksa Pharmaceuticals International, plc (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
Kiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference Transcript
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why
Court Ruling & Tariff Uncertainty: Time to Bet on POST, TME & KNSA?
Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade